Skip to main content

Advertisement

SpringerLink
Log in

Die Chemotherapiesequenz vor oder nach Strahlentherapie hat keinen Einfluss auf das Überleben der Kinder mit Hochrisiko-Medulloblastomen

Ergebnisse der multizentrischen und randomisierten Studie der Pediatric Oncology Group (POG 9031)

The chemotherapy before or after radiation therapy does not influence survival of children with high-risk medulloblastomas

Results of the multicenter and randomized study of the Pediatric Oncology Group (POG 9031)

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Tarbell NJ, Friedman H, Polkinghorn WR et al. (2013) High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031) J Clin Oncol 31:2936–41

    Google Scholar 

  2. Chi SN, Gardner SL, Levy AS et al (2004) Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol 22:4881–4887

    Article  CAS  PubMed  Google Scholar 

  3. Evans AE, Jenkin RD, Sposto R et al (1990) The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572–582

    Article  CAS  PubMed  Google Scholar 

  4. Gandola L, Massimino M, Cefalo G et al (2009) Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma. J Clin Oncol 27:566–571

    Article  CAS  PubMed  Google Scholar 

  5. Krischer JP, Ragab AH, Kun L et al (1991) Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study. J Neurosurg 74:905–909

    Article  CAS  PubMed  Google Scholar 

  6. Mosijczuk AD, Nigro MA, Thomas PR et al (1993) Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study. Cancer 72:2755–2762

    Article  CAS  PubMed  Google Scholar 

  7. Packer RJ, Sutton LN, Elterman R et al (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81:690–698

    Article  CAS  PubMed  Google Scholar 

  8. Tait DM, Thornton-Jones H, Bloom HJ et al (1990) Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26:464–469

    CAS  PubMed  Google Scholar 

  9. Taylor RE, Bailey CC, Robinson KJ et al (2005) Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer 41:727–734

    Article  CAS  PubMed  Google Scholar 

  10. Hoff K von, Hinkes B, Gerber NU et al (2009) Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT’91. Eur J Cancer 45:1209–1217

    Article  Google Scholar 

  11. Zeltzer PM, Boyett JM, Finlay JL et al (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol 17:832–845

    CAS  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. R.-D. Kortmann gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. -, Leipzig, Deutschland

    R.-D. Kortmann

Authors
  1. R.-D. Kortmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kortmann, RD. Die Chemotherapiesequenz vor oder nach Strahlentherapie hat keinen Einfluss auf das Überleben der Kinder mit Hochrisiko-Medulloblastomen. Strahlenther Onkol 190, 106–108 (2014). https://doi.org/10.1007/s00066-013-0491-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-013-0491-2

Search

Navigation